XML 45 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details) - Schedule of stock options - Stock Options [Member] - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Stockholders' Equity (Details) - Schedule of stock options [Line Items]    
Number of Options, Beginning Balance (in Shares) 50,000,000
Weighted- Average Exercise Price, Beginning Balance $ 0.03
Weighted- Average Grant Date Fair Value, Beginning Balance $ 0.004
Weighted- Average Remaining Contractual Life (years), Beginning Balance   9 months
Number of Options, Ending Balance (in Shares) 200,000,000
Weighted- Average Exercise Price, Ending Balance $ 0.02
Weighted- Average Grant Date Fair Value, Ending Balance
Weighted- Average Remaining Contractual Life (years), Ending Balance 7 years 9 months 18 days
Number of Options, Granted (in Shares) 200,000,000
Weighted- Average Exercise Price, Granted $ 0.02
Weighted- Average Grant Date Fair Value, Granted $ 0.012
Weighted- Average Remaining Contractual Life (years), Granted 8 years 7 months 24 days
Number of Options, Exercised (in Shares)
Weighted- Average Exercise Price, Exercised
Weighted- Average Grant Date Fair Value, Exercised
Weighted- Average Remaining Contractual Life (years), Exercised
Number of Options, Expired (in Shares) 50,000,000
Weighted- Average Exercise Price, Expired
Weighted- Average Grant Date Fair Value, Expired
Weighted- Average Remaining Contractual Life (years), Expired
Number of Options, Cancelled (in Shares)
Weighted- Average Exercise Price, Cancelled
Weighted- Average Grant Date Fair Value, Cancelled
Weighted- Average Remaining Contractual Life (years), Cancelled
Number of Options, Options exercisable at end of period (in Shares) 100,000,000  
Weighted- Average Exercise Price, Options exercisable at end of period $ 0.0074  
Weighted- Average Grant Date Fair Value, Options exercisable at end of period $ 0.0096  
Weighted- Average Remaining Contractual Life (years), Options exercisable at end of period 6 years 1 month 24 days